Litigation Details for Fresenius Kabi USA LLC v. Claris Lifesciences Ltd. (D. Del. 2014)
✉ Email this page to a colleague
Fresenius Kabi USA LLC v. Claris Lifesciences Ltd. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-12-19 |
| Court | District Court, D. Delaware | Date Terminated | 2015-04-17 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 8,476,010 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Fresenius Kabi USA LLC v. Claris Lifesciences Ltd.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Fresenius Kabi USA LLC v. Claris Lifesciences Ltd. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-12-18 | 1 | infringement of United States Patent No. 8,476,010 (“the ʼ010 patent”). This action arises out of Claris… BACKGROUND The Patent-in-Suit: United States Patent No. 8,476,010 … of the ’010 patent. COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,476,010 BY …rights, title, and interest in the ʼ010 patent. The ʼ010 patent is listed in the FDA publication “Approved…. The ʼ010 patent will expire on June 1, 2025. A true and accurate copy of the ʼ010 patent is attached | External link to document | |
| 2014-12-18 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,476,010 B2;. (dmp, ) (Entered…2014 17 April 2015 1:14-cv-01498 830 Patent None District Court, D. Delaware | External link to document | |
| 2015-04-17 | 6 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,476,010 B2. (Attachments:…2014 17 April 2015 1:14-cv-01498 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
